Earnings call transcript: Itera posts stronger Q2 2026 margins, shares edge up

Itera reported Q2 revenue of NOK 210m (+4% Y/Y) with 7% underlying growth in local currency, while adjusted EBIT margin jumped to 6.8% from 2.3% (+450 bps) amid improving billable utilization and lower overhead/headcount. Cash flow from operations was NOK 18.6m, but trailing cash conversion fell to 58% (working-capital/timing driven), and the company flagged continued NOK strength as a headwind of ~3 percentage points for Q3–Q4 2026. Despite only a modest 0.31% early-stock move to $6.44, management highlighted AI/agentic transformation demand and expects no significant one-off costs in 2H 2026.

Analysis

The real signal is that AI is becoming a delivery and workflow product, not just a capex story. That tends to favor services firms with domain specialization, security/compliance credentials, and reusable IP, while commoditized body-shop models face margin pressure as agentic tooling reduces billable-seat growth. In listed names, ACN and IBM are better positioned than higher-beta implementation shops because they can monetize governance, managed services, and transformation at scale; this is not a fresh NVDA read-through so much as a confirmation that demand is broadening beyond chips.

Near term, the cleanest reversal factor is FX and cash conversion. If reported growth keeps getting clipped by currency while working capital fails to normalize over the next 1-2 quarters, the market will reclassify this as a quality-of-earnings story rather than a genuine acceleration. The next catalyst window is 1-3 months: booking conversion, margin hold-through after one-offs, and any evidence that AI pilots are turning into multi-quarter deployments.

Contrarian view: consensus is likely still underpricing how much AI raises productivity for niche consultants that capture knowledge into reusable assets, which can lift recurring revenue and reduce the linear link between headcount and growth. But the move is probably underowned rather than overbought; the limitation is liquidity and the need for hard proof that cash generation improves, not just EBIT. If cash conversion stays sub-65% or new bookings roll over, the thesis weakens quickly.

Key Decisions for Investors

• Long ACN on weakness over the next 1-3 months; use it as the cleaner proxy for AI implementation and managed-services monetization. Risk/reward: modest upside from multiple support if enterprise IT spend re-accelerates, but cut if consulting bookings or guidance soften.
• Pair trade: long IBM / short EPAM for 1-3 months. IBM has better exposure to regulated modernization, security, and sovereignty-driven demand, while EPAM is more exposed to discretionary digital projects and margin noise; thesis fails if EPAM re-accelerates bookings faster than IBM.
• Do not add to NVDA on this tape; treat the article as confirmation, not a new catalyst. Keep existing exposure only if you want broad AI beta, but wait for next capex or hyperscaler commentary before increasing risk.
• Set an alert on small-cap IT services names for cash conversion improvement over the next two quarters; if conversion remains below 65% or FX headwinds widen, fade any post-earnings enthusiasm rather than chase margin optics.